Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Modern Innovative TCM Technology is a China-based traditional Chinese medicine and healthcare technology company focused on modernizing TCM research, formulation development, quality control, and manufacturing equipment. The company was founded in 2017 and appears to operate as a multi-shareholder industry platform backed by major Chinese pharmaceutical groups and Tianjin-based institutional shareholders. Its activities span development and translation of classic TCM formulas, quality-evaluation and analytical methods, probiotic and ginseng-related compositions, and intelligent equipment such as TCM sorting and ingredient-detection systems. Public descriptions indicate the company has helped translate research into products including Xuanfei Baidu granules and is involved in the Modern TCM Manufacturing Innovation Center. Overall, it looks more like a modern TCM innovation and industrialization platform than a single-asset clinical biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Modern Innovative TCM Technology.